Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Halford

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Theoretical Biology|March 24, 2005
Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replicationWilliam P Halford, Keith J Halford, Amy T Pierce
Journal of Virology|December 15, 2010
Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infectionChristopher D Conrady, William P Halford, Daniel J J Carr
Virology|March 12, 2002
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/betaPeter Härle, Bruno Sainz, Daniel J J Carr, et al.
Plos One|December 17, 2015
Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2William P Halford, Joshua Geltz, Ronald J Messer, et al.
Plos One|June 27, 2015
The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious VirionsSvetlana Gershburg, Joshua Geltz, Karin E Peterson, et al.
Journal of Neuroimmunology|December 2, 2008
Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathwaysDaniel J J Carr, Bobbie A Austin, William P Halford, et al.
Plos One|March 18, 2011
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccineWilliam P Halford, Ringo Püschel, Edward Gershburg, et al.
Journal of Virology|June 5, 2009
Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal gangliaYumi Imai, Kathleen Apakupakul, Philip R Krause, et al.
Plos Pathogens|October 15, 2011
The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularizationTodd Wuest, Min Zheng, Stacey Efstathiou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in corneaBobbie Ann Austin, William P Halford, Bryan R G Williams, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Theoretical Biology|March 24, 2005
Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replicationWilliam P Halford, Keith J Halford, Amy T Pierce
Journal of Virology|December 15, 2010
Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infectionChristopher D Conrady, William P Halford, Daniel J J Carr
Virology|March 12, 2002
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/betaPeter Härle, Bruno Sainz, Daniel J J Carr, et al.
Plos One|December 17, 2015
Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2William P Halford, Joshua Geltz, Ronald J Messer, et al.
Plos One|June 27, 2015
The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious VirionsSvetlana Gershburg, Joshua Geltz, Karin E Peterson, et al.
Journal of Neuroimmunology|December 2, 2008
Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathwaysDaniel J J Carr, Bobbie A Austin, William P Halford, et al.
Plos One|March 18, 2011
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccineWilliam P Halford, Ringo Püschel, Edward Gershburg, et al.
Journal of Virology|June 5, 2009
Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal gangliaYumi Imai, Kathleen Apakupakul, Philip R Krause, et al.
Plos Pathogens|October 15, 2011
The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularizationTodd Wuest, Min Zheng, Stacey Efstathiou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in corneaBobbie Ann Austin, William P Halford, Bryan R G Williams, et al.
Pageof 4